HB1079

House Bill 1079 mandates that health benefit plans in Arkansas provide coverage for specific genetic testing and evidence-based cancer imaging for individuals who meet certain criteria. To qualify for coverage, the genetic testing must show clinical utility, be recommended by a healthcare provider, and align with recognized medical guidelines such as those from the National Comprehensive Cancer Network or Medicare. Similarly, evidence-based cancer imaging is required for individuals at an increased risk of cancer when supported by clinical utility and recognized standards of care. The bill stipulates that this mandated coverage is generally exempt from annual deductibles, copayments, or coinsurance, with specific exceptions for certain state employee health plans and self-funded government plans. It also includes provisions to ensure compatibility with federal health savings account (HSA) regulations. The bill is set to take effect on January 1, 2026, and empowers the Insurance Commissioner to create rules for its implementation.